Dawnay, Day Sirius
09 May 2007
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION,
DISTRIBUTION OR RELEASE IN, OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES,
CANADA, AUSTRALIA OR JAPAN.
DAWNAY, DAY SIRIUS LIMITED
ANNOUNCEMENT OF EXERCISE OF OVER-ALLOTMENT OPTION
Dawnay, Day Sirius Limited (the 'Company'), today announces that, in connection
with the initial public offering of the Company completed on 4 May 2007 (the
'Offer'), JPMorgan Cazenove Limited, as stabilising manager, has today given
notice to exercise the over-allotment option in respect of 27,800,000 ordinary
shares of the Company. The €27.1 million net proceeds arising from the exercise
of the over-allotment arrangements will be received by the Company.
Following the issue of the ordinary shares pursuant to the exercise of the
over-allotment option, there will be 327.8 million ordinary shares of the
Company in issue, of which 27.8 million will be held by Staracre Limited (a
company owned as to 50% by Marba Investments and as to 50% by Frank and Kevin
Oppenheim).
Application has been made for the 27,800,000 ordinary shares to be issued
pursuant to the over-allotment option to be admitted to trading on AIM.
Further Enquiries
Sirius Facilities Group Kevin Oppenheim 020 7861 0550
www.dawnaydaysirius.com Alistair Marks
JPMorgan Cazenove Robert Fowlds 020 7588 2828
Bronson Albery
Cardew Group Tim Robertson 020 7930 0777
M: 07900 927 650
Shan Shan Willenbrock
Catherine Maitland
These materials are not for publication or distribution, directly or indirectly,
in, into or from the United States of America, Canada, Australia or Japan. These
materials do not constitute or form part of any offer or invitation to sell or
issue or any solicitation of any offer to purchase or subscribe for any
securities in any jurisdiction, nor shall it (or any part of it) or the fact of
its distribution form the basis of, or be relied upon in connection with, or act
as any inducement to enter into, any contract or commitment therefor.
The shares mentioned herein have not been, and will not be, registered under the
US Securities Act of 1933 (the 'Securities Act'), and may not be offered or sold
in the United States except pursuant to an exemption from the registration
requirements of the Securities Act. No public offer of the shares is being made
in the United States and the information contained herein does not constitute an
offering or securities for sale in the United States, Canada, Australia or
Japan. No money, securities or other consideration is being solicited and, if
sent in response to the information contained herein, will not be accepted.
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.